Huang, W-C <br/><br/>
Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.  [electronic resource] 

 -  Eye (London, England)  Feb 2009 
 - 488-9 p.  digital 
<br/><br/> Publication Type: Case Reports; Letter 
<br/><br/><label>ISSN: </label>1476-5454 
<br/><br/><label>Standard No.: </label>10.1038/eye.2008.55  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Central Serous Chorioretinopathy--drug therapy<br/>Chronic Disease<br/>Humans<br/>Male